Autopsy report · NCT00809354
Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip
Cause of deathNo reason given
“See termination reason in detailed description.”
Life of this trial
- Registered 2 months before it started.
- Ran for about 1 year 11 months before it stopped.
- 2,720 participants enrolled.
- Results were posted on the registry 10 years 5 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Osteoarthritis; Arthritis
- Interventions
- NSAID; tanezumab; tanezumab; tanezumab; NSAID; tanezumab
- Participants
- 2,720
- Sites
- 333
- Countries
- Canada, Colombia, India, Mexico, Netherlands, Philippines, Russia, South Africa, South Korea, Spain, Ukraine, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.